Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma

Citation:

Abuhelwa AY, Almansour SA, Basch E, Al-Shamsi HO, Abuhelwa Z, Bustanji Y, Semreen MH, Kharaba Z, Ali SM, Mohamed R, Kichenadasse G, McKinnon RA, Sorich MJ, Alzoubi KH, Hopkins AM. Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma. Eur J Haematol. 2025 Mar 14. doi: 10.1111/ejh.14410. Epub ahead of print. PMID: 40084510.